|
|
EY-01Y4447
|
Tanespimycin, 97%, a potent HSP90 inhibitor with an IC50 of 5 nM, having a 100-fold higher binding affinity for tumour cell derived HSP90 than normal cell derived HSP90
|
75747-14-7
|
10MG、25MG
|
￥0.0
|
|
|
|
EY-01Y4412
|
Oxytetracycline dihydrate, 98%
|
6153-64-6
|
10G、50G
|
￥0.0
|
|
|
|
EY-01Y4792
|
Potassium tetraoxalate dihydrate, 98.5%
|
6100-20-5
|
25G、100G、500G、1KG
|
￥0.0
|
|
|
|
EY-01Y3529
|
Glycylglycylglycylglycine
|
637-84-3
|
1G、100MG
|
￥0.0
|
|
|
|
EY-01Y5034
|
Sodium tetraborate decahydrate, 99.5%, for analysis,PH:9.0 - 9.5 (5% soln.at 25 ℃)
|
1303-96-4
|
100G、1KG、5KG
|
￥0.0
|
|
|
|
EY-01Y4519
|
Tetracycline-HCl research grade
|
64-75-5
|
100G
|
￥0.0
|
|
|
|
EY-01Y4383
|
Tetracycline hydrochloride, 98%
|
64-75-5
|
25G、100G
|
￥0.0
|
|
|
|
EY-01Y4620
|
Tetracycline hydrochloride, 96%
|
64-75-5
|
25g、100g
|
￥0.0
|
|
|
|
EY-01Y4479
|
Puromycin dihydrochloride
|
58-58-2
|
25mg、100mg、500mg
|
￥0.0
|
|
|
|
EY-01Y4517
|
Puromycin-2HCl research grade
|
58-58-2
|
10MG
|
￥0.0
|
|
|
|
EY-01Y5102
|
POPSO disodium salt, 99%
|
108321-07-9
|
5G、25G、100G
|
￥0.0
|
|
|
|
EY-01Y5032
|
Piperazine-N,N′-bis(2-ethanesulfonic acid), 99%
|
5625-37-6
|
25G、100G、500G
|
￥0.0
|
|
|
|
EY-01Y5161
|
Piperazine-1,4-bis(2-ethanesulfonic Acid) Monosodium Salt [Good's buffer component for biological research]
|
10010-67-0
|
25G
|
￥0.0
|
|
